scispace - formally typeset
Journal ArticleDOI

Quantitative structure–activity relationship analysis and virtual screening studies for identifying HDAC2 inhibitors from known HDAC bioactive chemical libraries

TLDR
This study illustrates the power of ML-based QSAR approaches for the screening and discovery of potent, isoform-selective HDACIs.
Abstract
Histone deacetylases (HDAC) are emerging as promising targets in cancer, neuronal diseases and immune disorders. Computational modelling approaches have been widely applied for the virtual screening and rational design of novel HDAC inhibitors. In this study, different machine learning (ML) techniques were applied for the development of models that accurately discriminate HDAC2 inhibitors form non-inhibitors. The obtained models showed encouraging results, with the global accuracy in the external set ranging from 0.83 to 0.90. Various aspects related to the comparison of modelling techniques, applicability domain and descriptor interpretations were discussed. Finally, consensus predictions of these models were used for screening HDAC2 inhibitors from four chemical libraries whose bioactivities against HDAC1, HDAC3, HDAC6 and HDAC8 have been known. According to the results of virtual screening assays, structures of some hits with pair-isoform-selective activity (between HDAC2 and other HDACs) were revealed. This study illustrates the power of ML-based QSAR approaches for the screening and discovery of potent, isoform-selective HDACIs.

read more

Citations
More filters
Journal ArticleDOI

Small molecule HDAC inhibitors: Promising agents for breast cancer treatment.

TL;DR: In conclusion, HDACs have shown desirable effects on breast cancer, especially when they are used in combination with other anticancer agents, and more multicenter and randomized Phase III studies are expected to be conducted pushing promising new therapies closer to the market.
Journal ArticleDOI

Quinazoline-Based Hydroxamic Acids: Design, Synthesis, and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity

TL;DR: Detailed investigation on the estimation of absorption, distribution, metabolism, excretion, and toxicity (ADMET) suggested that compounds 4g, 6c, and 6g, while showing potent HDAC2 inhibitory activity and cytotoxicity, also potentially displayed ADMET characteristics desirable to be expected as promising anticancer drug candidates.
Journal ArticleDOI

Evaluation of pyrrole-2,3-dicarboxylate derivatives: Synthesis, DFT analysis, molecular docking, virtual screening and in vitro anti-hepatic cancer study

TL;DR: Pyrrole-2,3-dicarboxylate derivatives synthesized in this study significantly inhibited the growth of HepG2 cells in a dose-dependent manner and may be proven to be novel therapeutic candidates to cure cancer.
Journal ArticleDOI

Conformal prediction of HDAC inhibitors.

TL;DR: This work introduces a novel approach for epigenetic quantitative structure–activity relationship (QSAR) modelling using conformal prediction and discusses the development of models for 11 sets of inhibitors of histone deacetylases, which are one of the major epigenetic target families that have been screened.
References
More filters
Journal ArticleDOI

Chemistry, Biology, and QSAR Studies of Substituted Biaryl Hydroxamates and Mercaptoacetamides as HDAC Inhibitors—Nanomolar‐Potency Inhibitors of Pancreatic Cancer Cell Growth

TL;DR: To investigate the potential for isoform selectivity in the inhibition of HDACs, a small series of 2,4′‐diaminobiphenyl ligands functionalized at the para‐amino group with an appendage containing either a hydroxamate or a mercaptoacetamide group and coupled to an amino acid residue at the ortho‐aminos group are prepared.
Journal ArticleDOI

3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment.

TL;DR: Comparative molecular field analysis and comparative molecular similarity indices analysis were performed on hydroxamate-based HDACs inhibitors based on phamacophore alignment and revealed important structural features of the inhibitors related to the active site ofHDACs.
Journal ArticleDOI

Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agents.

TL;DR: It was found that several compounds with 6C-bridge linking benzothiazole moiety and hydroxamic functional groups showed good inhibition against HDAC3 and 4 and exhibited potent cytotoxicity against five cancer cell lines with average IC(50) values of as low as 0.81 μg/ml, almost equipotent to SAHA.
Journal ArticleDOI

QSAR Studies of PC-3 cell line inhibition activity of TSA and SAHA-like hydroxamic acids

TL;DR: Quantitative structure-activity relationships (QSAR) for a series of new trichostatin A (TSA)-like hydroxamic acids for the inhibition of cell proliferation of the PC-3 cell line have been developed using molecular descriptors from Qikprop and electronic structure calculations.
Related Papers (5)